SCHEMBL4839227

SCHEMBL4839227

COc1ccc2c(c1)/C(=C/C(=O)c1cccc(NC(=O)COCc3ccccc3)c1)NC(C)(C)C2

nearest known ligand 0.47

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 3/20 0.40
NPC1 O15118 3/20 0.40
HPGD P15428 3/20 0.40
USP2 O75604 1/20 0.40
PARP1 P09874 1/20 0.40
RAB9A P51151 3/20 0.39
KMT2A Q03164 2/20 0.39
MEN1 O00255 1/20 0.39
PTPRC P08575 1/20 0.39
PTPN1 P18031 1/20 0.39
MAPT P10636 3/20 0.39
PIK3CG P48736 1/20 0.38
TDP1 Q9NUW8 1/20 0.38
KDM4E B2RXH2 1/20 0.37
LMNA P02545 1/20 0.37
GLA P06280 1/20 0.37
GAA P10253 1/20 0.37
HTT P42858 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4839240 1.00 ALDH1A1 (0.40) ALDH1A1NPC1HPGDUSP2PARP1
SCHEMBL4835773 0.92 NAMPT (0.42) ALDH1A1NPC1RAB9AKMT2AMEN1
SCHEMBL4835779 0.92 NAMPT (0.42) ALDH1A1NPC1RAB9AKMT2AMEN1
SCHEMBL4839782 0.90 USP2 (0.52) ALDH1A1NPC1USP2RAB9AKMT2A
SCHEMBL4839756 0.90 USP2 (0.52) ALDH1A1NPC1USP2RAB9AKMT2A
SCHEMBL4840989 0.90 NPC1 (0.53) ALDH1A1NPC1HPGDRAB9AMAPT
SCHEMBL4840982 0.90 NPC1 (0.53) ALDH1A1NPC1HPGDRAB9AMAPT
SCHEMBL4837848 0.89 ALDH1A1 (0.45) ALDH1A1NPC1HPGDRAB9AKMT2A
SCHEMBL4837826 0.89 ALDH1A1 (0.45) ALDH1A1NPC1HPGDRAB9AKMT2A
SCHEMBL4835750 0.89 RAB9A (0.53) ALDH1A1NPC1HPGDUSP2PARP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7378428-B2 Nitrogen-containing bicyclic compounds and drugs containing the same as the active ingredient ONO PHARMACEUTICAL CO., LTD. (JP) 2008-05-27 US disclosed
US-20050222138-A1 Nitrogen-containing bicyclic compounds and drugs containing the same as the active ingredient ONO PHARMACEUTICAL CO., LTD. (JP) 2005-10-06 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050222138-A1 Nitrogen-containing bicyclic compounds and drugs containing the same as the active ingredient PARK7, MMP8, CDK7 ALDH1A1 2636/4885NPC1 985/4885HPGD 1185/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.